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a  b  s  t  r  a  c  t
Transsphincteric  resection  of  rectal  tumors  was  ﬁrst described  about  120 years  ago.  Nowadays,  this
approach  faded into  obscurity  due  to standardized  guidelines  and  practice  in  surgical  oncology  includ-
ing  lymphadenectomy,  mesorectal  excision  and radical  dissection  of  veins.  However,  transsphinctericccepted 17 December 2015
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resection  seems  reasonable  in  some  cases,  especially  if an  abdominal  approach  can  be avoided.
In the  following,  we will present  and describe  the  technique  of  the  transsphincteric  approach  with  its
variations  in  rectal  surgery  in  the  case of a rare pararectal  tumor.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).raske approach
. Introduction
Access to the anal canal, the distal rectum and the mesorectum
an be established by splitting the sphincter. Kocher and Verneuil
escribed in 1875 the posterior exposure of the rectum through a
occyx resection [1]. One year later, Cripps described in a series
f 36 patients access to the rectum through a transsphincteric
pproach. Despite the lack of sphincteric reconstruction, 2/3 of the
atients did not develop anal incontinence. In 1885, Kraske mod-
ﬁed the approach by gaining access through a pararectal incision
ith resection of the sacrum to avoid dissection of the sphincter
2]. In the following years, several publications conﬁrmed the fea-
ibility of this technique, however, the abdominal approach for the
reatment of benign and malignant tumors in the pelvis became the
gold standard’ [3].
In 1974 York Mason modiﬁed the technique by reconstructing
he sphincter after initial dissection with good results on postop-
rative anal continence [4].
Huber, von Hochstetter and Allgöwer reintroduced the anatomy
nd its clinical relevance of the pelvis and its relation to sphinc-
eric reconstruction, which lead to the implementation of surgical
echnique, anatomical and physiological knowledge into today’s
urgery [5].
The dorsal transsphincteric approach is an applicable tech-
ique that allows the surgeon to operate on the distal rectum and
esorectum without opening the abdominal cavity.
∗ Corresponding author at: University Hospital for General and Visceral Surgery,
linikum Oldenburg, Rahel-Straus-Str. 10, 26133 Oldenburg, Germany.
E-mail address: troja.achim@klinikum-oldenburg.de (A. Troja).
ttp://dx.doi.org/10.1016/j.ijscr.2015.12.027
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing Gro
reativecommons.org/licenses/by-nc-nd/4.0/).2. Deﬁnition
The dorsal transsphincteric approach describes a surgical tech-
nique that allows access to the mesorectum, the distal part of the
rectum and the anal canal by dissecting the levator ani and part of
the sphincter through a parasacral incision.
3. Surgical technique
Prior to surgery the rectum should be mechanically prepared.
The patient is then placed into the prone position. The incision
should run parasacral, about 3 ﬁnger width above the coccyx, down
to the anocutan line. The distance to the sacrum should be 1 ﬁnger
width. Following the dissection through the subcutaneous tissue,
the M.  gluteus maximus is split at the cranial part of the incision
displaying the sacrospinal ligament cranially and the external anal
sphincter caudally. The musculature of the pelvic ﬂoor should be
dissected medially sparing its innervation and perfusion. Depend-
ing on the location, size and type of the tumor, dissection of the
sphincter musculature might be necessary. While dissecting the
levator ani and the external and internal sphincter, it might be
useful to ligate the musculature facilitating a later reconstruction.
Once the dissection is completed the Waldeyer’s fascia can be
identiﬁed and resected along with the tumor thus gaining access to
the mesorectum. The rectum can then be mobilised along the rec-
toprostatic fascia. If the preparation needs to be extended cranially,
dissection of the sacrospinal ligament is necessary.Once resection is completed, the corresponding parts of the
levator ani and sphincter can be sewn together. Gathering of the
puborectal muscle can be discussed to prevent possible prolapse
or incontinence.
up Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. T1-MRI-Scan: the tumour is hypervascularized in the Fossa ischioanalis.
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Fig. 3. Angiography: the tumour vessels origin at internal iliac artery angiography:
the tumour vessels origin at interal iliac artery.
Fig. 4. Expression of Ki-67 antigen (6%).ig. 2. T2-MRI-Scan: the tumour in sagittal projection in the mesorectal tissue.
. Case report
We  present the case of a 60-year-old male patient who  received
n abdominal computed tomography for unintentional weight loss
f 3 kg. An upper endoscopy revealed a long-barret esophagus. A
olposcopy was normal. Clinical examination revealed no patho-
ogical ﬁndings.
The CT of the abdomen and pelvis described a 9 × 6 × 6 cm
ypvervascularized solitary tumor pararectal in the fossa
schioanalis. A MRT  conﬁrmed the presence of the tumor with
umor-supplying vessels from the A. iliaca interna. An inﬁltration
f neighboring organs was excluded (Figs. 1 and 2).
We  decided to embolize the tumor preoperatively followed by a
ranssphincteric tumor resection (Fig. 3). The surgical resection was
erformed as outline above. The tumor was extirpated followed
y reconstruction of the pelvic ﬂoor. The rectum was not affected
uring the procedure.
The patient was discharged on the 7th postoperative day. Dur-
ng patient follow-up a superﬁcial wound-healing deﬁcit developed
hich was treated accordingly and healed secondary. The patient
ad no symptoms regarding anal incontinence.
. HistologyThe histopathological examination revealed a solitary and vas-
ularized tumor with an immunohistochemical CD34-reactivity
nd a nuclear STAT6-expression. In addition 6% of the cell nuclei
xpressed the Ki-67-Antigen (Fig. 4). The tumor cells showed aFig. 5. Expression of vimentin.
positive reaction toward the Vimentin (Fig. 5) antibody with nega-
tive markers for the S-100 antibody. The results of the conventional
histology showing a solitary vascularized tumor (Fig. 6), and the
immunohistochemical analysis suggest the diagnosis of a solitary
ﬁbrous tumor.
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We present the case of a patient with a solitary ﬁbrous tumor. AFig. 6. HE-histology: well vascularized tumour.
. Solitary ﬁbrous tumor
The tumor entity was ﬁrst described in 1931. Less than 2% of
ll soft-tissue-tumors belong to this group [6]. Most tumors of this
ype are benign, however, 10–15% are malignant and highly aggres-
ive with the formation of distant metastasis. The micromophology
f the tumor does not give relevant information about its growth
haracteristics [7].
For many years it was believed that solitary ﬁbrous tumors are
estricted to the pleura or the mesothelium. Recent studies regard-
ng its histogenesis revealed a much more heterogenous picture,
howing signs of ﬁbroblastic and myoﬁbroblastic origin [8].
For a long time hemangiopericytoma was used as a synonym,
lthough the recent WHO  classiﬁcation deﬁnes hemangiopericy-
oma as a subgroup of SFTs [9,10].
The histopathological examination in combination with the
mmunohistochemistry is crucial for diagnosing SFT. The charac-
eristic microscopic changes are described as “patternless pattern”
ith hypo- and hypercellular areas and so-called “staghorn” pat-
ern with ectatic tumor vessels [11]. The additional information
iven by the immunohistochemistry allows further discrimination
mong the differential diagnosis such as sarcomas, metastases or
IST. Typical positive markers are CD34, Vimentin, bcl-2 and CD99.
ontrary, markers such as S100, actin, SMA, CEA and keratin are typ-
cally not present [12,13]. Current analysis showed that a nuclear
xpression of STAT-6, as presented in our case, is a very speciﬁc
arker for the presence of a SFT [14,15].
Malignant SFTs can present with speciﬁc features but without
 related causality. Histopathological results do not suggest a spe-
iﬁc biological growth pattern of SFTs. Generally, large tumors with
typical cell nuclei, more than 4 mitosis/10HPF, growth of necrotic
real and hemorrhages are criteria for a malignant potential. A ret-
ospective analysis described a patient age >55 years, a tumor size
15 cm and a high mitotic index as risk factors for metastasis and
 increased mortality [16]. Also benign SFTs have the potential to
evelop into malignancies. It was shown histochemically that the
eaction to CD34 decreases while there is an overexpression of S100
nd p53 [17]. It is also known that some parts of SFTs are well-
ifferentiated while others are not. Moleculargenetic analysis have
hown that the mutation of p53 and NAB2-STAT6 inﬂuence the
linical growth pattern of SFTs [18,19].
SFTs of the small pelvis as described in this case are rare. Most
FTs present in the 5th decade and are usually asymptomatic. Once
he tumor reached a certain size, causing displacement of adja-
ent organs, it becomes symptomatic. Symptoms range between
iffuse abdominal pain, impaired bladder emptying and related
eurological symptoms involving the sacral plexus. In addition,PEN  ACCESS
ery Case Reports 19 (2016) 159–162 161
hypoglycaemia is possible due to tumors producing insulin-like
growth factor [20].
With the knowledge of a potential malignant transformation,
radical surgical tumor extirpation is the treatment of choice. The
5-year survival rate is close to 100% after a R0-resection [21].
Guidelines on safety margins do not exist. A follow-up is indi-
cated, however, duration and frequency for follow-up visits are not
deﬁned.
There are some cases of recurrencies that presented many years
after the primary resection of the tumor, indicating a long follow-
up. In the case of recurrence or metastases, surgery remains the
treatment of choice. The use of radiotherapy and chemotherapy
(e.g., doxorubicin) has been described, however, no signiﬁcant
change in long-time survival was  achieved [22,23].
In the case of non-resectable SFTs, Espat and others were able to
show certain positive effects due to the implementation of antian-
giogenetic therapeutics [21].
7. Discussion
This case demonstrates the possibility of a pararectal approach
in extirpating a tumor of the small pelvis. Due to the tumor
biology of a SFT, R0-resection is absolutely necessary to prevent
later recurrence. Achieving a R0-resection determines the prog-
nosis of the patient [24]. Extrapleural SFT can present across
the body area, however, SFTs affecting the mesorectum are very
rare. The histopathological and biological properties of pleural and
extrapleural SFTS are similar [25]. Metastases can appear years later
and should be surgically resectable, if possible.
A CT or MR  should be performed to diagnose a SFT. A
SFT cannot be safely differentiated from other tumors although
some SFT-related characteristics such as hypervascularisation with
hemorrhages, necrosis and cystic lesions within the tumor are
described. A hypervascularisation was  noticed in our case. There-
fore, a preoperative embolization was  performed. A MRT  can
identify a delineation or inﬁltration to adjacent structures and the
sacral vertebrae.
A posterior approach for resection of the tumor is only possible
if the tumor lies caudally to S3. Otherwhise an abdominal approach
is indicated.
By means of this case we  want to demonstrate the feasibility of
a posterior pararectal approach in resecting a tumor of the small
pelvis. This historic and neglected approach is indicated in some
instances and prevents complications such as hernias, postopera-
tive paralysis of the colon and injury to adjacent structures that
might follow open abdominal surgery.
As we  described above different types of posterior approaches
were described in the past. The usual opinion of these approaches is
that a transspincteric approach as described by Mason or modiﬁed
by Allgöwer might result in an anal incontinence. This is not correct.
In contrast to that it would by necessary to resect the coccys and
sometimes part of the sacrum as described by Kraske. Therefore it
may  result a larger wound defect. Also some patients describe an
unpleasant sensation after resection of the coccys.
That is the reason why we  would prefer the transsphincteric
resection and not the resection of coccys and/or sacrum.
R0-resection of SFTs is the treatment of choice. Preoperative
embolization facilitates the constraint on tumor perfusion and
related risk of intraoperative bleeding.
8. Summarypreoperative remobilisation of the tumor was performed followed
by a radical R0-resection through a posterior approach thus sparing
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